...
首页> 外文期刊>International ophthalmology clinics >Orbital Langerhans Cell Histiocytosis
【24h】

Orbital Langerhans Cell Histiocytosis

机译:眼眶朗格汉斯细胞组织细胞增生症

获取原文
获取原文并翻译 | 示例
           

摘要

Langerhans cell histiocytosis (LCH) is a rare disease with a long, confusing history. Formerly known as histiocytosis X, it is characterized by proliferation of cells with Langerhans cell (LC) characteristics. Annual incidence has been reported to be 3 to 7 cases per million people and its contribution to orbital disease in the general population is less than 1 % of orbital tumors. LCH is a predominantly pediatric condition with a male predominance. Although our knowledge of LCH expanded significantly over the past century, the pathogenesis remains enigmatic, and natural history and treatment of orbital LCH are not well defined due to its extreme rarity.
机译:朗格汉斯细胞组织细胞增生症(LCH)是一种罕见的疾病,具有悠久而混乱的历史。以前称为组织细胞增生症X,其特征是具有郎格罕斯细胞(LC)特征的细胞增殖。据报道,年发病率为每百万人3至7例,其对普通人群眼眶疾病的贡献不到眼眶肿瘤的1%。 LCH是一种以男性为主的儿童疾病。尽管我们对LCH的知识在过去的一个世纪中有了显着的发展,但其发病机理仍然是令人难以置信的,并且由于其极其稀有性,人们对轨道LCH的自然历史和治疗方法还没有很好的定义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号